Amundi Decreases Stake in Xylem Inc. $XYL

Key Points

• Amundi has reduced its stake in Xylem Inc. by 8.6% in Q1, now owning 2.01% of the company, valued at $557.28 million.
• Xylem reported a Q2 earnings per share (EPS) of $1.26, exceeding estimates, with revenue of $2.30 billion, up 6.1% from the previous year.
• The company announced a quarterly dividend of $0.40 per share, with a payout ratio of 41.56%, set to be paid on September 25th.

Amundi lowered its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 8.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,884,239 shares of the industrial products company's stock after selling 458,828 shares during the quarter. Amundi owned about 2.01% of Xylem worth $557,278,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Valley National Advisers Inc. increased its holdings in shares of Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after acquiring an additional 101 shares in the last quarter. Perkins Coie Trust Co acquired a new position in shares of Xylem during the first quarter valued at about $27,000. Center for Financial Planning Inc. increased its holdings in shares of Xylem by 52.0% during the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 91 shares in the last quarter. Heck Capital Advisors LLC acquired a new position in shares of Xylem during the fourth quarter valued at about $36,000. Finally, Headlands Technologies LLC increased its holdings in shares of Xylem by 90.6% during the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock valued at $36,000 after acquiring an additional 145 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Insider Transactions at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares of the company's stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on XYL shares. JPMorgan Chase & Co. started coverage on Xylem in a research note on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective for the company. UBS Group increased their price target on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a report on Tuesday, August 5th. Cowen reiterated a "hold" rating on shares of Xylem in a report on Tuesday, August 26th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, Citigroup reaffirmed a "buy" rating and set a $152.00 price objective (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. Six equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $152.29.

Xylem Price Performance

Xylem stock traded down $1.42 during trading on Friday, reaching $140.52. The company had a trading volume of 1,170,902 shares, compared to its average volume of 998,635. The firm's 50-day simple moving average is $137.36 and its 200 day simple moving average is $127.24. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33. The firm has a market capitalization of $34.20 billion, a PE ratio of 36.50, a price-to-earnings-growth ratio of 2.45 and a beta of 1.09. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. During the same quarter last year, the company earned $1.09 EPS. The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem's dividend payout ratio (DPR) is currently 41.56%.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.